Haryana FDA Busts Spurious Medicine Factory At Barwala

Panchkula : The Haryana Food and Drug Administration (FDA) busted a spurious medicine factory in Barwala, Panchkula, here on Friday. The factory allegedly used to supply spurious medicines from Barwala to Delhi. It is suspected to be a big racket of counterfeit medicines at national level.

As per the information shared by an FDA spokesperson, the officials of the department had earlier received complaints that counterfeit products of a medicine factory, Relieve Pharmaceuticals of Chandpur, Una, Himachal Pradesh, are being made and sold, from the owner Sukesh Chandra.

Acting on the information, a team was constituted under the leadership of FDA’s Assistant State Drug Controller Ripon Mehta, along with Senior Drug Control Officer, Ambala, Sunil Dahiya and drug control officer, Panchkula.

The team raided Cubic Light Science Private Limited, located at Industrial Area, Barwala, Panchkula, during which the team found 320 mg and 100 mg tablets which were branded as K2 tablets and with active ingredients calcium citrate, vitamin K-27, zinc and magnesium. The cost of these medicines has been estimated at Rs 5,69,940.

The manufacturer’s name printed on these counterfeit medicines was of Relieve Pharmaceuticals. The fake consignment of counterfeit medicines is said to have come from Bawana, Delhi. Sukesh Chandra informed the FDA team that they do not have any factory or office in Barwala or Delhi.

The team collected the sample of the medicines from the spot for testing and has seized the rest of the goods in its possession for further legal action. No police complaint has been registered yet and no arrests have been made in the matter.

The Delhi Drugs Department has been informed so that the racket can be busted. In the last few days, this is the fifth factory found making fake medicines.

  • Related Posts

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

    Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

    Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore